RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $42,000 | -96.1% | 7,643 | -93.1% | 0.00% | – |
| Q4 2021 | $1,080,000 | +200.0% | 111,494 | +452.5% | 0.00% | – |
| Q3 2021 | $360,000 | +146.6% | 20,181 | +235.9% | 0.00% | – |
| Q2 2021 | $146,000 | -81.9% | 6,008 | -80.3% | 0.00% | – |
| Q1 2021 | $807,000 | +414.0% | 30,469 | +48.1% | 0.00% | – |
| Q4 2020 | $157,000 | +12.1% | 20,571 | -25.7% | 0.00% | – |
| Q3 2020 | $140,000 | -25.1% | 27,677 | -11.3% | 0.00% | – |
| Q2 2020 | $187,000 | +167.1% | 31,220 | +99.0% | 0.00% | – |
| Q1 2020 | $70,000 | -79.0% | 15,685 | -55.2% | 0.00% | – |
| Q4 2019 | $333,000 | +103.0% | 35,000 | +66.4% | 0.00% | – |
| Q3 2019 | $164,000 | -65.0% | 21,035 | -29.4% | 0.00% | – |
| Q2 2019 | $468,000 | +140.0% | 29,813 | +175.3% | 0.00% | – |
| Q1 2019 | $195,000 | +6400.0% | 10,831 | +5315.5% | 0.00% | – |
| Q4 2018 | $3,000 | -97.2% | 200 | -95.6% | 0.00% | – |
| Q3 2018 | $109,000 | – | 4,555 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |